← Back to Clinical Trials
Recruiting NCT03275480
Institut Paoli Calmettes Myelodysplastic Syndromes Database
Trial Parameters
Condition Myelodysplastic Syndromes
Sponsor Institut Paoli-Calmettes
Study Type OBSERVATIONAL
Phase N/A
Enrollment 10,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2016-01-18
Completion 2030-01
Brief Summary
Database of Institut Paoli-Calmettes patients diagnosed with Myelodysplastic Syndromes
Eligibility Criteria
Inclusion Criteria: * Patient with a diagnosis of Myelodysplastic Syndromes Exclusion Criteria: * None
Related Trials
NCT05875805
A Telehealth Advance Care Planning Intervention
View Trial →
NCT06956755
Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia
View Trial →
NCT07238686
Venetoclax-containing Therapy Combined With Microtransplant for Intermediate-risk and Higher MDS
View Trial →